title: Characterization of a Multipeptide Lantibiotic Locus in Streptococcus pneumoniae.
abstract: Bacterial communities are established through a combination of cooperative and antagonistic interactions between the inhabitants. Competitive interactions often involve the production of antimicrobial substances, including bacteriocins, which are small antimicrobial peptides that target other community members. Despite the nearly ubiquitous presence of bacteriocin-encoding loci, inhibitory activity has been attributed to only a small fraction of gene clusters. In this study, we characterized a novel locus (the pld locus) in the pathogen Streptococcus pneumoniae that drives the production of a bacteriocin called pneumolancidin, which has broad antimicrobial activity. The locus encodes an unusual tandem array of four inhibitory peptides, three of which are absolutely required for antibacterial activity. The three peptide sequences are similar but appear to play distinct roles in regulation and inhibition. A modification enzyme typically found in loci encoding a class of highly modified bacteriocins called lantibiotics was required for inhibitory activity. The production of pneumolancidin is controlled by a two-component regulatory system that is activated by the accumulation of modified peptides. The locus is located on a mobile element that has been found in many pneumococcal lineages, although not all elements carry the pld genes. Intriguingly, a minimal region containing only the genes required for pneumolancidin immunity was found in several Streptococcus mitis strains. The pneumolancidin-producing strain can inhibit nearly all pneumococci tested to date and provided a competitive advantage in vivo. These peptides not only represent a unique strategy for bacterial competition but also are an important resource to guide the development of new antimicrobials.
  
  
  OBJECTIVE
  Successful colonization of a polymicrobial host surface is a prerequisite for the subsequent development of disease for many bacterial pathogens. Bacterial factors that directly inhibit the growth of neighbors may provide an advantage during colonization if the inhibition of competitors outweighs the energy for production. In this work, we found that production of a potent antimicrobial called pneumolancidin conferred a competitive advantage to the pathogen Streptococcus pneumoniae. S. pneumoniae secreting pneumolancidin inhibits a wide array of Gram-positive organisms, including all but one tested pneumococcal strain. The pneumolancidin genetic locus is of particular interest because it encodes three similar modified peptides (lantibiotics), each of which has a distinct role in the function of the locus. Lantibiotics represent a relatively untapped resource for the development of clinically useful antibiotics which are desperately needed. The broad inhibitory activity of pneumolancidin makes it an ideal candidate for further characterization and development.
authors.affiliation: Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.
authors.forename: Natalie
authors.initials: N
authors.lastname: Maricic
authors.affiliation: Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan, USA.
authors.forename: Erica S
authors.initials: ES
authors.lastname: Anderson
authors.affiliation: Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan, USA.
authors.forename: AnneMarie E
authors.initials: AE
authors.lastname: Opipari
authors.affiliation: Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan, USA.
authors.forename: Emily A
authors.initials: EA
authors.lastname: Yu
authors.affiliation: Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan, USA sdawid@umich.edu.
authors.forename: Suzanne
authors.initials: S
authors.lastname: Dawid
mesh_terms: D000595:Amino Acid Sequence; D000898:Antibiosis; D001430:Bacteriocins / Q000235:genetics* / Q000378:metabolism*; D015964:Gene Expression Regulation, Bacterial; D023061:Gene Order; D056426:Genetic Loci; D020071:Interspersed Repetitive Sequences; D008826:Microbial Sensitivity Tests; D008969:Molecular Sequence Data; D016415:Sequence Alignment; D034361:Streptococcus mitis / Q000235:genetics; D013296:Streptococcus pneumoniae / Q000235:genetics* / Q000378:metabolism*
chemical_list: D001430:Bacteriocins
references.citation: Science. 2006 Sep 15;313(5793):1636-7
references.pmid: 16973881
references.citation: J Biol Chem. 2007 Jul 20;282(29):21169-75
references.pmid: 17513866
references.citation: Mol Microbiol. 2008 May;68(3):768-85
references.pmid: 18394148
references.citation: J Biol Chem. 1995 Nov 10;270(45):27299-304
references.pmid: 7592991
references.citation: MBio. 2011;2(5). pii: e00179-11. doi: 10.1128/mBio.00179-11
references.pmid: 21896678
references.citation: Infect Immun. 1999 Aug;67(8):4268-71
references.pmid: 10417203
references.citation: BMC Genomics. 2015;16:554
references.pmid: 26215050
references.citation: Appl Environ Microbiol. 2014 Feb;80(3):1062-71
references.pmid: 24271178
references.citation: Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8710-5
references.pmid: 15928084
references.citation: PLoS One. 2011;6(2):e17035
references.pmid: 21386965
references.citation: J Bacteriol. 2013 Apr;195(7):1561-72
references.pmid: 23354751
references.citation: J Bacteriol. 2013 Dec;195(24):5592-601
references.pmid: 24123816
references.citation: Eur J Biochem. 1999 Apr;261(2):524-32
references.pmid: 10215865
references.citation: Infect Immun. 2007 Jan;75(1):443-51
references.pmid: 17074857
references.citation: Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17243-8
references.pmid: 17085596
references.citation: Antimicrob Agents Chemother. 2005 Feb;49(2):541-8
references.pmid: 15673730
references.citation: J Am Chem Soc. 2009 Dec 9;131(48):17563-5
references.pmid: 19911780
references.citation: Microbiology. 2000 Sep;146 ( Pt 9):2147-54
references.pmid: 10974102
references.citation: Appl Environ Microbiol. 1993 Jan;59(1):296-303
references.pmid: 8439156
references.citation: Microbiology. 2002 Nov;148(Pt 11):3561-8
references.pmid: 12427947
references.citation: Antimicrob Agents Chemother. 2010 Oct;54(10):4416-23
references.pmid: 20643901
references.citation: BMC Genomics. 2013;14:500
references.pmid: 23879707
references.citation: J Clin Microbiol. 2014 May;52(5):1590-4
references.pmid: 24599973
references.citation: Genome Announc. 2013 Jul 25;1(4):null
references.pmid: 23887920
references.citation: Microb Drug Resist. 1998 Winter;4(4):325-37
references.pmid: 9988052
references.citation: MBio. 2014;5(4):e01490-14
references.pmid: 25053789
references.citation: Science. 2004 Jan 30;303(5658):679-81
references.pmid: 14752162
references.citation: MBio. 2011;2(1):e00245-10
references.pmid: 21285435
references.citation: PLoS One. 2009;4(8):e6788
references.pmid: 19707558
references.citation: J Biol Chem. 2014 Oct 3;289(40):27899-910
references.pmid: 25118291
references.citation: Appl Environ Microbiol. 2014 Apr;80(8):2633-43
references.pmid: 24532070
references.citation: Peptides. 2004 Sep;25(9):1415-24
references.pmid: 15374645
references.citation: J Bacteriol. 2009 Mar;191(5):1480-9
references.pmid: 19114491
references.citation: Science. 2006 Mar 10;311(5766):1464-7
references.pmid: 16527981
references.citation: Antimicrob Agents Chemother. 2010 Sep;54(9):3895-906
references.pmid: 20606066
references.citation: J Bacteriol. 2010 Jun;192(11):2801-8
references.pmid: 20382768
references.citation: PLoS One. 2011;6(1):e15951
references.pmid: 21283517
references.citation: J Bacteriol. 1993 May;175(9):2578-88
references.pmid: 8478324
references.citation: Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7258-63
references.pmid: 23589847